Researcher
Benoit Beuselinck
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Feb 2011 → Today
Projects
1 - 6 of 6
- Response prediction in metastatic clear-cell renal cell carcinoma treated with angiogenesis and/or immune checkpoint inhibitorsFrom1 Oct 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Medication-related osteonecrosis of the jaw (MRONJ) - Balancing treatments benefits and risksFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom5 Dec 2019 → 30 Sep 2021Funding: BOF - projects
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORTARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom1 Oct 2019 → TodayFunding: FWO fellowships
- Patient selection strategies throughout the renal cell carcinoma disease spectrumFrom1 Aug 2019 → 6 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
31 - 40 of 152
- Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications(2021)
Authors: Eduard Roussel, Lisa Kinget, Bram Boeckx, Marcella Baldewijns, Steven Joniau, Hendrik Van Poppel, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
Pages: 1499 - 1506 - Three Years After CARMENA: What Have We Learned?(2021)
Authors: Eduard Roussel, Benoit Beuselinck, Maarten Albersen
Pages: 425 - 427 - Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors.(2021)
Authors: Lisa Kinget, Oliver Bechter, Kevin Punie, Hilde Brems, Paul Clement, Eduard Roussel, Yannick Van Herck, Maarten Albersen, Marcella Baldewijns, Patrick Schöffski, et al.
Pages: 3227 - 3239 - Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study(2021)
Authors: Benoit Beuselinck
Pages: 354 - 361 - MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma(2021)
Authors: Lisa Kinget, Eduard Roussel, Maarten Albersen, Annouschka Laenen, Marcella Baldewijns, Benoit Beuselinck
Pages: 1 - 15 - Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis(2021)
Authors: Benoit Beuselinck
Pages: 820 - 826 - MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma(2021)
Authors: Lisa Kinget, Eduard Roussel, Diether Lambrechts, Bram Boeckx, Maarten Albersen, Annouschka Laenen, Marcella Baldewijns, Benoit Beuselinck
- Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma(2021)
Authors: Benoit Beuselinck
- Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors(2021)
Authors: Benoit Beuselinck
Pages: 102 - 111 - Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium(2021)
Authors: Benoit Beuselinck
Pages: 1212 - 1221